ID
42549
Descrição
Study ID: 110921 Clinical Study ID: 110921 Study Title: A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00811733 Clinicaltrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT00811733 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Ofatumumab Trade Name: N/A Study Indication: Waldenstrom Macroglobulinaemia The primary objective of this open-label, multi-center, Phase II study was to evaluate the safety and efficacy of Ofatumumab in subjects diagnosed with Waldenstrom Macroglobulinaemia. For the study, eligible subjects were enrolled to receive up to 3 cycles of treatment with Ofatumumab. The first cycle consisted of a single dose of 300 mg followed by 3 weekly doses of 1000 mg (Treatment Group A) or 4 weekly doses of 2000 mg (Treatment Group B) of Ofatumumab, with response assessment beginning at Week 12. Based on the Week 12-16 response, eligible subjects could receive up to 2 additional cycles of treatment. This form has to be filled whenever/if additional scans have to be done during study.
Link
https://clinicaltrials.gov/ct2/show/NCT00811733
Palavras-chave
Versões (1)
- 25/08/2021 25/08/2021 -
Titular dos direitos
GlaxoSmithKline
Transferido a
25 de agosto de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733
Additional Scan
- StudyEvent: ODM
Descrição
Other protocol specified and/or additional scan
Alias
- UMLS CUI-1
- C2348563
- UMLS CUI-2
- C0011923
- UMLS CUI-3
- C0205394
- UMLS CUI-4
- C1524062
Descrição
Scan Method
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C0871511
Descrição
Date of Scan
Tipo de dados
date
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C0011008
Descrição
Anatomic location of image coverage
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1515974
Descrição
Other anatomic location of image coverage
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1515974
- UMLS CUI [1,3]
- C0205394
Descrição
Reminder: Any new lesions identified need to be indicated on the Response form and the details of the new lesions need to be entered onto the New Lesion form.
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C3146298
Descrição
Reminder: Any new lesions identified need to be indicated on the Response form and the details of the new lesions need to be entered onto the New Lesion form.
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C3146298
- UMLS CUI [1,3]
- C0205394
Descrição
If the result of the scan is unequivocal progression, ensure the Response Assessment form is completed.
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1274040
Descrição
If the result of the scan is unequivocal progression, ensure the Response Assessment form is completed.
Tipo de dados
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C1629507
Similar models
Additional Scan
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0011923 (UMLS CUI-2)
C0205394 (UMLS CUI-3)
C1524062 (UMLS CUI-4)
C0011008 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C1629507 (UMLS CUI [1,3])
Sem comentários